Tag - RSVpreF vaccine

GHP News Latest Science

Critical summary of the BERNI study:
Real-world effectiveness of maternal RSVpreF vaccination in Argentina

Reference Pérez Marc G, Vizzotti C, Fell DB, et al. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during...

7 October, 2025

6 min read

GHP News Latest Science

How to best prevent RSV in infants?

Significant progress has been made in preventing respiratory syncytial virus (RSV) infections in infants, with the licensing of at least three prophylactic products. RSV-associated hospitalization rates reach...

7 October, 2025

6 min read

GHP News Latest Science

RSV prefusion F vaccine for prevention of hospitalization in older adults

The DAN-RSV phase 4 pragmatic randomized trial evaluated the effectiveness and safety of the bivalent RSV prefusion F protein–based vaccine (RSVpreF) in adults aged 60 years and older during the 2024–2025 season in...

9 September, 2025

2 min read

Latest Science

Co-administration of RSV, influenza vaccines found safe and effective in new study

The co-administration of bivalent respiratory syncytial virus (RSV) prefusion F protein−based vaccine (RSVpreF) and seasonal influenza vaccine was found to generate robust immune responses and was safe and well...

6 December, 2023

3 min read

Tag - RSVpreF vaccine

Critical summary of the BERNI study:Real-world effectiveness of maternal RSVpreF vaccination in Argentina

How to best prevent RSV in infants?

RSV prefusion F vaccine for prevention of hospitalization in older adults

Co-administration of RSV, influenza vaccines found safe and effective in new study

Critical summary of the BERNI study:
Real-world effectiveness of maternal RSVpreF vaccination in Argentina